Participated · Series A · Apr 2026

Agriodor develops a class of crop protection solutions that use semiochemicals to influence insect behavior by replicating natural plant scents. Its R&D platform combines high-throughput chemical ecology and reverse chemical ecology to design blends that attract, repel, or disrupt pest insects while preserving beneficial species. The company launched its first commercial product targeting sugar beet aphids and has an exclusive distribution agreement with Syngenta, with an initial field deployment in France. Agriodor is expanding its product portfolio to address additional insect families including fruit flies, whiteflies, and thrips. Founded in 2019 as a spin-off from INRAE by Alain Thibault and Dr Ené Leppik, the company plans to use the Series A funding to accelerate international expansion and wider deployment of its olfactory biocontrol technology.

Led · Series A · Feb 2026

Founded in 2017, UBEES combines beekeeping expertise with IoT-enabled hives and agronomic analytics to embed structured pollination into commercial farming systems. Its connected beehives are fitted with sensors that track pollinator health, environmental conditions, and indicators such as crop quality, biodiversity, and carbon footprint. The resulting data powers recommendations that help farmers and agri-food brands optimise yields, enhance ecosystem resilience, and verify environmental impact. The company supports clients from programme design through on-the-ground implementation and currently operates in more than fifteen countries across five continents, serving sectors that include food, cosmetics, and energy. Future plans include deepening technological capabilities in hive-embedded sensors, expanding impact-measurement tools, and building an international network of trained farmers. With fresh capital, UBEES will intensify its presence in Europe and the United States while accelerating expansion in Latin America and Africa, key regions for pollination-dependent crops such as coffee, berries, avocados, and cocoa. The firm also intends to create additional income opportunities for smallholder farmers by scaling beekeeping practices alongside improved agronomic data access.

Led · Series A · Oct 2025

Founded in 2021 by Alexandros Pantalis and Adèle James, Phagos engineers bacteriophage (phage) treatments through a proprietary platform that combines microbiology with artificial intelligence. Its patented AI analyses complete phage and bacterial genomes to predict interactions and design precise, adaptable therapies as pathogens evolve. The company’s first commercial focus is veterinary medicine, where it has already secured regulatory authorisation to market personalised phage-based treatments aimed at reducing antibiotic use in livestock. Longer term, Phagos intends to expand these solutions to human health applications. With antimicrobial resistance driving millions of deaths and heavy economic costs, management positions the technology as a scalable global standard for bacterial infection control. The recent €25 million Series A financing provides capital to scale veterinary product deployment, advance the next generation of its AI, and grow the team to support market launches and international expansion. No operating metrics such as revenue or user counts were disclosed in the article.

Participated · Series B · Sep 2025

Founded in Norway in 2011, Nofence pioneered the world’s first commercial virtual fencing system for cattle, sheep and goats. Its solar-powered collars use GPS and mobile networks to define digital boundaries and deliver escalating audio warnings followed by a mild electric pulse if an animal crosses the line, all managed through an easy-to-use app. The technology supports rotational grazing, lowers labor and production costs, and improves land stewardship, making it attractive to climate-conscious farmers. Adoption has grown from pilot projects in 2016 to more than 150,000 collars sold, and the company now employs about 90 people across Norway, the UK, Ireland, Spain and the United States. Recent hiring of a U.S. managing director and national sales director underscores a push into the American market, where producers in 48 states are already using the product. With fresh capital, Nofence plans to accelerate expansion in North America and Europe, advance product development, and deepen customer support. Investor enthusiasm highlights the firm’s momentum and positions it to make virtual fencing a global standard in livestock management.

Participated · Series B · Dec 2021

La Belle Vie operates an online grocery store in the Paris area, originally focusing on fresh products such as vegetables, fruit, meat, fish and cheese. It has expanded its assortment to include packaged goods and now offers about 17,000 products, including 4,000 fresh items, and has a partnership with Système U. The service delivers across Île-de-France in under three hours, processes roughly 15,000 orders per week, and employs around 500 people (the CEO also cited over 600 employees on permanent contracts). To compete with quick-commerce players the company launched a faster brand, Bam Courses, in Paris with a 2,500-product assortment dispatched from seven distribution hubs and targeted 15-minute deliveries. La Belle Vie emphasizes profitability and tight control of margins and supply chain, and plans to expand to other major cities in France. La Belle Vie focuses exclusively on groceries, offering a large inventory of basics, organic items, meat, fish, vegetables and prepared meals after acqui-hiring 62degrés. The startup has built its own stack from scratch, including an ERP, warehouse management and delivery management services. In 2017 the company generated $3.5 million (€3 million) in sales. It competes with services such as Amazon Prime Now and supermarket delivery offerings in Paris. With its new funding, La Belle Vie plans to open a second warehouse in Paris and expand to new cities, starting with Lyon. The product proposition emphasizes optimizing every step of grocery fulfillment for faster delivery and higher specialization than generalist services.